Enzymatic measurement of imatinib mesylate
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 27, 2007
Grant Date -
May 18, 2006
app pub date -
Nov 14, 2005
filing date -
Nov 18, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a method for the enzymatic measurement of protein tyrosine kinase inhibitors in biological samples. The present invention also provides assay reagents and packaged kits useful for performing enzymatic measurement of imatinib mesylate and other bcr-abl protein kinase inhibitors in biological samples.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully